Skip to main content
Premium Trial:

Request an Annual Quote

Source BioScience Acquires ImaGenes for $3.1M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Source BioScience today said that it has acquired genomics research products and services firm ImaGenes for £2 million ($3.1 million).

London-based Source BioScience originally built its business in the histopathology market. But over the past three years, it has added contract research services including DNA sequencing, genotyping, and gene expression analysis. The acquisition of ImaGenes will provide it with a variety of genomic products for genotyping, gene expression, and bioinformatics, as well as protein arrays, sequencing services, and cDNA and genomic clone products and libraries.

ImaGenes also is a certified service provider for both Agilent and Roche NimbleGen technologies, which complements Source BioScience's existing microarray services and status as a certified service provider for Illumina technologies.

Berlin-based ImaGenes had revenues of £2.5 million for full-year 2009, and a loss before tax of £24,000. The firm was formed in 2007 from a management buyout of part of the German Resource Centre for Genomics and currently employs 30 people.

"The acquisition of ImaGenes provides a platform for increased penetration of the European life science research and healthcare markets, acting as a catalyst for accelerated growth," Source BioScience CEO Nick Ash said in a statement. "The ImaGenes team will bring significant depth of experience and knowledge to the group and we will be able to leverage their existing links with academic centres and research institutions across Europe."

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.